OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mitochondrial survivin reduces oxidative phosphorylation in cancer cells by inhibiting mitophagy
Amelia R. Townley, Sally P. Wheatley
Journal of Cell Science (2020) Vol. 133, Iss. 21
Open Access | Times Cited: 15
Amelia R. Townley, Sally P. Wheatley
Journal of Cell Science (2020) Vol. 133, Iss. 21
Open Access | Times Cited: 15
Showing 15 citing articles:
Mitophagy at the crossroads of cancer development: Exploring the role of mitophagy in tumor progression and therapy resistance
K Deepak, Pritam Roy, Chandan Kanta Das, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2024) Vol. 1871, Iss. 6, pp. 119752-119752
Closed Access | Times Cited: 12
K Deepak, Pritam Roy, Chandan Kanta Das, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2024) Vol. 1871, Iss. 6, pp. 119752-119752
Closed Access | Times Cited: 12
CK2 and the Hallmarks of Cancer
May-Britt Firnau, Angela Brieger
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1987-1987
Open Access | Times Cited: 27
May-Britt Firnau, Angela Brieger
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1987-1987
Open Access | Times Cited: 27
Survivin as a Therapeutic Target for the Treatment of Human Cancer
Qiang Wang, Mark I. Greene
Cancers (2024) Vol. 16, Iss. 9, pp. 1705-1705
Open Access | Times Cited: 4
Qiang Wang, Mark I. Greene
Cancers (2024) Vol. 16, Iss. 9, pp. 1705-1705
Open Access | Times Cited: 4
Molelcuar regulation of mitophagy signaling in tumor microenvironment and its targeting for cancer therapy
Bishnu Prasad Behera, Soumya Ranjan Mishra, Srimanta Patra, et al.
Cytokine & Growth Factor Reviews (2025)
Closed Access
Bishnu Prasad Behera, Soumya Ranjan Mishra, Srimanta Patra, et al.
Cytokine & Growth Factor Reviews (2025)
Closed Access
The SMAC mimetic GDC-0152 is a direct ABCB1-ATPase activity modulator and BIRC5 expression suppressor in cancer cells
I‐Li Lin, Yu-Ting Lin, Yung-Chieh Chang, et al.
Toxicology and Applied Pharmacology (2024) Vol. 485, pp. 116888-116888
Closed Access | Times Cited: 3
I‐Li Lin, Yu-Ting Lin, Yung-Chieh Chang, et al.
Toxicology and Applied Pharmacology (2024) Vol. 485, pp. 116888-116888
Closed Access | Times Cited: 3
Survivin/BIRC5 as a novel molecular effector at the crossroads of glucose metabolism and radioresistance in head and neck squamous cell carcinoma
Ester Benaiges, Victòria Ceperuelo‐Mallafré, Sandra Guaita, et al.
Head & Neck (2024) Vol. 46, Iss. 7, pp. 1752-1765
Open Access | Times Cited: 2
Ester Benaiges, Victòria Ceperuelo‐Mallafré, Sandra Guaita, et al.
Head & Neck (2024) Vol. 46, Iss. 7, pp. 1752-1765
Open Access | Times Cited: 2
Effects of triggers of senescence and senolysis in murine pancreatic cancer cells
Denis Revskij, Aline Woitas, Bianca Kölle, et al.
Hepatobiliary & pancreatic diseases international (2024) Vol. 23, Iss. 6, pp. 628-637
Closed Access | Times Cited: 2
Denis Revskij, Aline Woitas, Bianca Kölle, et al.
Hepatobiliary & pancreatic diseases international (2024) Vol. 23, Iss. 6, pp. 628-637
Closed Access | Times Cited: 2
Parkin exerts the tumor‐suppressive effect through targeting mitochondria
Xin Sun, Guiqin Ye, Yuanyuan Mai, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 4, pp. 855-871
Closed Access | Times Cited: 6
Xin Sun, Guiqin Ye, Yuanyuan Mai, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 4, pp. 855-871
Closed Access | Times Cited: 6
Short-Term Treatment with Rho-Associated Kinase Inhibitor Preserves Keratinocyte Stem Cell Characteristics In Vitro
Vignesh Jayarajan, George T. Hall, Theodoros Xenakis, et al.
Cells (2023) Vol. 12, Iss. 3, pp. 346-346
Open Access | Times Cited: 5
Vignesh Jayarajan, George T. Hall, Theodoros Xenakis, et al.
Cells (2023) Vol. 12, Iss. 3, pp. 346-346
Open Access | Times Cited: 5
Tumor-Suppressor Role of the α1-Na/K-ATPase Signalosome in NASH Related Hepatocellular Carcinoma
Utibe-Abasi Udoh, Moumita Banerjee, Pradeep Rajan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7359-7359
Open Access | Times Cited: 7
Utibe-Abasi Udoh, Moumita Banerjee, Pradeep Rajan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7359-7359
Open Access | Times Cited: 7
Survivin as a Therapeutic Target for the Treatment of Human Cancer
Qiang Wang, Mark I. Greene
(2024)
Open Access
Qiang Wang, Mark I. Greene
(2024)
Open Access
The survivin-ran inhibitor LLP-3 decreases oxidative phosphorylation, glycolysis and growth of neuroblastoma cells
Celimene Galiger, Fatema Tuj Zohora, Carmen Dorneburg, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Celimene Galiger, Fatema Tuj Zohora, Carmen Dorneburg, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Short-term Rho-associated kinase inhibitor treatment accelerates primary keratinocyte growth while preserving stem cell characteristics
Vignesh Jayarajan, George T. Hall, Theodoros Xenakis, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Vignesh Jayarajan, George T. Hall, Theodoros Xenakis, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Traveling Through Mitosis With the Chromosomal Passenger Complex
Michael E. Bekier, Radhika Koranne, William R. Taylor
Elsevier eBooks (2022), pp. 285-297
Closed Access
Michael E. Bekier, Radhika Koranne, William R. Taylor
Elsevier eBooks (2022), pp. 285-297
Closed Access
